TAURIGA SCIENCES, INC. (OTCMKTS:TAUG) Files An 8-K Unregistered Sales of Equity Securities
Item 3.02 Unregistered Sales of Equity Securities.
The Company, on January 14, 2019, announced that it has reached an agreement to extinguish the $75,000 contingent liability that originated from its December 2016 sale (the “Sale”) of its interest in Pilus Energy LLC (“Pilus Energy”) to Open Therapeutics LLC (“Open Therapeutics”). Set forth herein (for informational purposes only, and not incorporation by reference herein) is the link to the Company’s December 2016 press release disclosing the Sale: http://www.marketwired.com/press-release/tauriga-sciences-inc-sells-majority-stake-pilus-energy-subsidiary-open-therapeutics-pinksheets-taug-2185449.htm. Accordingly, this $75,000 contingent liability will be removed from the Company’s balance sheet during the Company’s current fiscal quarter, and shall be reflected in the Company’s upcoming quarterly report to be filed with the Securities and Exchange Commission. To extinguish this contingent liability, the Company agreed to a one-time restricted stock issuance of 500,000 Company shares, payable to Open Therapeutics LLC.
Item 7.01 Regulation FD Disclosure.
The information in Sections 7 and 9 of this Current Report on Form 8-K, including the information set forth in the Exhibit, is furnished to Item 7.01 of Form 8-K and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section. As such, this information shall not be incorporated by reference into any of the Company’s reports or other filings made with the Securities and Exchange Commission.
The press release announcing the settlement of the above-described liability is furnished as Exhibit 99.1 to this current report on Form 8-K.
Item 9.01 Exhibits Statements and Exhibits
|99.1||Press Release, dated January 14, 2019|
TAURIGA SCIENCES, INC. Exhibit
EX-99.1 2 ex99-1.htm New York,…
To view the full exhibit click
About TAURIGA SCIENCES, INC. (OTCMKTS:TAUG)
Tauriga Sciences, Inc. is a diversified company. The Company is focused on the development of technology platform in the nano-robotics space. The Company is engaged in acquiring and building a portfolio of technology assets.